CVKD

Cadrenal Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for kidney disease and related conditions. The company's research programs target treatments for acute kidney injury, chronic kidney disease, and complications arising from renal dysfunction. Cadrenal Therapeutics pursues novel drug candidates designed to protect kidney function and improve outcomes for patients with renal disorders. The company operates in the nephrology pharmaceutical sector, addressing a significant unmet medical need given the prevalence of kidney disease worldwide.